Obringer, F. (2011). Chinese medicine and the enticement of heritage status. China Perspectives, 2011, 15-22. https://doi.org/10.4000/chinaperspectives.5621
F. ObringerChinese medicine Heritage designation Intangible cultural heritage
Voir
Yang, M., Zhang, D. -K., He, Y. -N., Han, L., Wang, F., & Xu, R. -C. (2021). [Challenges and strategies of high-quality development of Indigo Naturalis industry]. Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal Of Chinese Materia Medica, 46, 3171-3179. https://doi.org/10.19540/j.cnki.cjcmm.20210521.301 (Original work published jul)
Ming Yang Ding-Kun Zhang Ya-Nan He Li Han Fang Wang Run-Chun Xuarticle child Chinese drug Chinese medicine Drugs Chinese Herbal Humans Indigo Carmine Indigo Naturalis Indigofera Industrial transformation inheritance and innovation Medicine Chinese Traditional Processing equipment Processing principle Psoriasis child colitis drug industry drug quality dye fever herbaceous agent human indigo carmine indigo naturalis Inheritance leukemia processing psoriasis unclassified drug
Voir